0071A

Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 10 mcg/0.2ml dosage, diluent reconstituted, tris-sucrose formulation; first dose